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Purpose: The purpose of this study was to determine the incidence, timing, and outcome 
of further thrombotic events after an initial episode of acute deep venous thrombosis. 
Methods: Venous thrombi n 204 lower extremities (177 patients) were monitored with 
duplex ultrasonography at intervals of I day, 7 days, i month, every 3 months for I year, 
and yearly thereafter. 
Results: Among initially involved extremities, propagation tonew segments occurred in 61 
(30%) and rethrombosis occurred in 63 (31%). Both propagation and rethrombosis, in
different segments, occurred in 27 (13%) extremities. New thrombi were also noted in 
nine (6%) initially uninvolved extremities. These events were not associated with 
identifiable clinical risk factors, although extremities with rethrombosis were more 
extensively involved at presentation. Propagation i  initially involved extremities was an 
early event, occurring within a median of 40 days in all segments. New thrombotic events 
in initiaUy uninvolved extremities and rethrombosis occurred as later events. The 
development of reflux was significantly more common among aU initially uninvolved 
segments o which thrombus extended and among mid and distal superficial femoral and 
popliteal artery segments with rethrombosis. 
Conclusions: Recurrent thrombotic events are common after acute deep venous thrombosis 
and adversely affect he ultimate development of valvular incompetence. Their occurrence 
is unrelated to recognized clinical risk factors and can occur despite standard anticoagu- 
lation measures. (J VASC SURG 1995;22:558-67.) 
Recanalization of the venous lumen is now 
recognized as a common phenomenon after an 
episode of deep venous thrombosis (DVT).I-4 How- 
ever, further thrombotic events, including extension 
of thrombus to previously uninvolved segments and 
rethrombosis of involved segments, have also been 
recognized clinically and in natural history studies of 
acute DVT. Indeed, thrombus evolution is perhaps 
best regarded as a dynamic process, with recanaliza- 
tion and further thrombotic events occurring as 
competing processes in many patients. The balance 
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between these processes seems to favor recanalization 
in most patients, resulting in eventual reestablish- 
ment of the venous lumen. However, thrombotic 
events occurring after initial presentation may have 
important implications for valve function and even- 
tual development of  the postthrombotic syndrome. 
Furthermore, both propagation 5 and rethrombosis 6 
have been associated with an increased risk of  
pulmonary embolism. 
The determinants ofvalve function after an acute 
DVT remain incompletely understood. The time 
required for complete recanalization has previously 
been shown to be an important determinant ofvalve 
competence. 2 However, lysis times are not the sole 
determinant of  valve fimction as illustrated by the 
small number of  venous segments eventually devel- 
oping reflux despite relatively rapid lysis. It is likely 
that other factors, including further thrombotic 
insults, contribute to the eventual development of 
re~ux. 
The purpose of this study was to determine the 
incidence and timing of  thrombotic events occurring 
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after initial presentation with an acute DVT, as well 
as the impact of these events on ultimate valve 
function, in a series of patients monitored prospec- 
tively with duplex ultrasonography. For the purpose 
of this study, such thrombotic events were defined to 
include rethrombosis of a partially occluded or 
recanalized venous segment (rethrombosis), propa- 
gation of thrombus to uninvolved segments in the 
ipsilateral limb (propagation), and development of 
new thrombi n a contralateral uninvolved extremity 
(new contralateral thrombi). 
PATIENTS AND METHODS 
Between January 1987 and June I994, all patients 
admitted to the University of Washington Medical 
Center with an acute lower extremity DVT con- 
firmed by venous duplex ultrasonography ave been 
asked to participate in a long-term study of the 
natural history of DVT. The study protocol was 
approved by the Human Subjects Committee at the 
University of Washington, and informed consent was 
obtained at the time of enrollment. 
Patients consenting to participate were asked to 
return at intervals of 1 day, 7 days, i month, and 
every 3 months for the first year after diagnosis of an 
acute DVT. Follow-up visits occurred yearly after the 
first year. At each visit patients were questioned with 
regard to symptoms, risk factors, and treatment; he 
lower extremities were examined for sequelae of 
venous disease; and duplex ultrasonography was 
performed. Duplex examinations were performed 
with an Ultramark 8 or 9 scanner (Advanced 
Technology Laboratories, Bothell, Wash.) with the 
patient in the 15-degree reverse Trendelenburg 
position. A 5 MHz transducer was used to obtain an 
image of the cephalad venous segments, and a 10 
MHz transducer was used for the tibial veins. A 
pulsed-wave Doppler frequency ors  MHz was used 
throughout. 
To facilitate precise localization of thrombi, the 
veins of the lower extremity were divided into eight 
segments including the common femoral vein (CFV) 
cephalad to the saphenofemoral junction, the deep 
femoral vein (DFV), the proximal superficial femoral 
vein (SFP) distal to the saphenofemoral junction, the 
mid superficial femoral vein (SFM) over the midpor- 
tion of the thigh, the distal superficial femoral vein 
(SFD) proximal to the adductor hiatus, the popliteal 
vein (PPV), the paired posterior tibial veins (PTV), 
and the greater saphenous vein (GSV) caudal to the 
saphenofemoral junction. Although imaging of the 
iliac veins was routinely attempted, they were not 
included in this analysis because their retroperitoneal 
location prevents consistent compression and there- 
fore precise classification of these segments. Indi- 
vidual segments were classified as patent, partially 
occluded, or completely occluded on the basis of 
duplex criteria. Patent segments were completely 
compressible with scan head pressure and exhibited 
spontaneous flow with normal respiratory variation. 
Spontaneous flow may be normally absent in the 
posterior tibial veins; these segments were considered 
patent if they were completely compressible and 
demonstrated flow with distal augmentation. Partial 
occlusion was defined as normal or diminished flow 
in an incompletely compressible s gment. An incom- 
pressible segment without flow was considered 
completely occluded. Valvular reflux within a seg- 
ment was defined as reverse flow persisting for 2 
seconds or less with proximal compression or a 
Valsalva maneuver. 
Depending on whether a segment was involved 
initially, two types of subsequent events could be 
distinguished by ultrasound criteria. New segmental 
involvement was considered to have occurred if com- 
pletely or partially occluding thrombus was identified 
in a segment that was patent at the initial examina- 
tion. Rethrombosis of a segment was defined as pro- 
gression of a partially occluded segment to complete 
occlusion or ofa recanalized segment to either partial 
or complete occlusion. Because both legs were stud- 
ied, these ultrasound efinitions included three dis- 
tinct entities-the development of new thrombi n 
initially uninvolved extremities (new contralateral 
thrombi); propagation of thrombi to new segments 
in initially involved limbs (propagation); and re- 
thrombosis of segments thrombosed at presentation 
(rethrombosis). Newly involved segments (propaga- 
tion and new contralateral thrombi) were not in- 
cluded in the subsequent analysis of rethrombosis. 
The time interval to any of these three events was 
recorded, as well as the ultimate development of re- 
flux within a segment, anticoagulation status, and 
associated risk factors. 
Because most continuous variables were not 
normally distributed, all results are reported as the 
median and interquartile range (25th to 75th per- 
centile). All statistical comparisons were made with 
nonparametric methods by use of the Pearson 
chi-square with Yates correction or Fischer's exact 
test for categorical variables and the Mann-Whitney 
U test for continuous variables. Among extremities, 
comparisons of thrombus extent between groups 
were made by use of Kruskal-Wallis one-way analysis 
of variance with post-hoe comparisons by use of 
Dunn's test. 7 Contrasts between grouped segments 
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Fig. 1. Risk factors among study patients. Distribution of clinical risk factors for DVT among 
177 patients in the study. OCP represents oral contraceptives. 
within extremities were weighted according to the 
number of segments in each group and tested with 
McNemar's test. Comparisons of time to event 
among the eight individual segments were made by 
use of Kruskal-Wallis one-way analysis of variance, 
which assumes independence among the segment 
categories. Because nrollment in this study has been 
continuous, follow-up times have differed among 
patients. In evaluating the development ofreflux, the 
effects of rethrombosis and follow-up duration were 
evaluated by use of logistic regression. Statistical 
significance was defined as ap value < 0.05. 
RESULTS 
Demographics. Since January 1987, 177 pa- 
tients with DVT of 204 lower extremities have been 
enrolled in this follow-up study. This group included 
98 (55%) men and 79 (45%) women, with a median 
age of 54.9 (interquartile range 38.5 to 67.3) years. 
DVT was unilateral on the right side in 56 (32%) 
patients, on the left side in 94 (53%) patients, and 
bilateral in 27 (15%) patients. At the time of 
presentation, a median of 4.0 (3.0 to 6.0) segments 
per extremity were involved. Median follow-up from 
the time of enrollment in the study was 9.3 (1.2 to 
34.9) months. 
In addition to age, cfinical risk factors for DVT 
were considered to include a family history of DVT, 
concurrent malignancy, pregnancy, use of oral con- 
traceptives, recent surgery, trauma, congestive heart 
failure, prolonged bed rest, or recent extended ( > 6 
hours) travel. Enrolled patients had a median of i risk 
factor per subject (1.0 to 2.0), with only 29 patients 
having no risk factors for DVT. The frequency of 
these risk factors among the study population is 
illustrated in Fig. 1. 
Thrombotic events within extremities. Propa- 
gation, rethrombosis, or new contralateral thrombi 
were identified in 106 extremities in 92 (52%) 
patients. New thrombi developed in nine previously 
uninvolved extremities (6%). Among initially in- 
volved limbs, propagation alone Occurred in 34 
extremities, rethrombosis alone in 36 extremities, 
and both propagation and rethrombosis (in different 
segments) in 27 extremities. Thus, among initially 
involved extremities, thrombus propagation oc- 
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Fig. 2. Risk factors for further thrombotic events. Distribution of clinical risk factors among 
ipsilatcral extremities with thrombus propagation, rethrombosis, both events, or neither event. 
No statistical difference is present among roups for any risk factor. CHF represents congestive 
heart failure, OCP represents oral contraceptives. 
curred in a total of 61 (30%) and rethrombosis in 63 
(31%) limbs. 
Both propagation and rethrombosis were usually 
limited to a few segments. Among the 61 extremities 
with propagation to ipsilateral venous segments, 
thrombus extended to a median of 1.0 (interquartile 
range 1.0 to 3.0) new segment. Only one or two new 
segments were involved in 70.5% of extremities. 
Similarly, rethrombosis affected a median of 1.0 
segments (1.0 to 2.0), with only one or two segments 
involved in 84.2% of such cases. In contrast, new 
thrombotic events in the contralateral limb involved 
a median of 4.0 segments (2.0 to 7.0) and involved 
four or more segments in 55.5% of the extremities. 
Among initially involved extremities, further 
thrombotic events were related to the extent of the 
initial thrombus. Significant differences in the initial 
extent of  thrombus were present in those extremities 
with propagation alone, rethrombosis alone, both 
events, and with neither propagation or rethrom- 
bosis (p = 0.001). Propagation tended to occur in 
extremities with less extensive thrombosis, whereas 
rethrombosis occurred in those with more extensive 
thrombosis. A median of 3.0 (interquartile range 2.0 
to 4.3) segments were initially involved in limbs with 
subsequent propagation, in comparison to 5.0 (4.0 
to 6.0) segments in extremities with rethrombosis 
and 4.0 segments in those with either both (3.0 to 
5.0) or neither (2.0 to 6.0) event. Post hoc compari- 
son showed the initial extent of involvement to be 
significantly greater in those with rethrombosis as 
compared to those with propagation alone 
(p < 0.001) or with neither event (p < 0.05). The 
fewer number of segments involved in those with 
propagation was not significantly different from 
those without further events. In contrast to events in 
the ipsilateral extremity, the development of new 
thrombi in an initially uninvolved limb was unrelated 
to the extent of  contralateral thrombus. 
In comparison to extremities without propaga- 
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Fig. 3. Median time to new segmental involvement. Time of thrombus extension to 
uninvolved segments in limbs with (propagation) and without (new contralateral thrombi) 
DVT at presentation. Error bars denote interquartile range (25th to 75th percentile). Differences 
are statistically significant (p < 0.03) for SFP, SFD, and PPV segments. 
Table I. Anticoagulation status at the time of subsequent thrombotic events 
Re~romb~ 
Initially involved limb Uninvolved limb 
Propagation New thrombi 
No. % No. % Anticoagulation No. % 
Heparin 6 9.5 
Warfarin 29 46 
Both heparin and 6 9.5 
warfarin 
None 18 28.6 
Unknown 4 6.3 
TOTAL  63 
9 14,8 2 22.2 
19 31.1 5 55.6 
8 13,1 1 11.1 
21 4,4 1 
4 6,6 0 
6-T 
11.1 
tion or rethrombosis, these events were not sig- 
nificantly associated with age, sex, side of involve- 
ment, or clinical risk factors including prolonged 
bed rest, malignancy, surgery, a family history of 
DVT, heart failure, use of oral contraceptives, 
pregnancy, recent trauma, or recent prolonged 
travel (Fig. 2). Similarly, the development of new 
thrombi n the contralateral extremity was unrelated 
to any of these factors. Because the treatment of all 
patients in the study was at the discretion of their 
primary physician, we have no data regarding the 
adequacy of anticoagulation in these patients. How- 
ever, at the time of the subsequent thrombotic 
event, 88.9% of contralateral extremities with new 
thrombosis, 59.0% of ipsilateral extremities with 
propagation and 65.0% of those with rethrombosis 
were being treated with heparin, warfarin, or both 
(Table I). 
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Table II. Thrombotic events among individual venous egments 
Rethrombosis Propagation New contralateral D VT 
Segment Segments at risk s Rethrombosis Segments at risk ~ Propagation Segments at risks New thrombi 
CFV 291 22 (24,2%) 113 17 (15.0%) 150 5 (3.3%) 
GSV 27 2 (7.4%) 177 8 (4.5%) 150 3 (2.0%) 
DFV 57 3 (5.3%) 147 10 (6.8%) 150 2 (3.3%) 
SFP 109 17 (15.6%) 95 13 (13.7%) 150 5 (3.3%) 
SFD 115 20 (17.4%) 89 14 (15.7%) 150 5 (3.3%) 
PPV 143 21 (14.7%) 61 9 (14.8%) 150 7 (4.7%) 
PTV 146 11 (7.5%) 262 29 (10.3%) 300 9 (3.0%) 
*Number of segments initially involved. 
~Number ofuninvolved segments in ipsilateral extremity. 
SNumber of segments in initially uninvolved xtremities. 
Table III. Median time to propagation and rethrombosis in initially involved extremities 
Propagation time 25th to 75th Rethrombosis time 25th to 75th 
Segment No. (days) percentile No. (days) percentile p Value ~ 
CFV 17 31.0 5.0-49.5 22 62.5 6.0-182.0 0.37 
GSV 8 13.5 3.0-83.8 2 61.0 34.0-88.0 0.43 
DFV 10 39.5 6.0-612.0 3 7.0 1.0-38.0 0.23 
SFP 13 9.0 3.5-43.0 17 41.0 13.0-293.5 0.03 
SFM 14 15.0 5.8-88.3 14 61.0 17.8-275.8 0.17 
SFD 14 10.0 5.0-41.0 20 232.5 55.8-556.3 0.0005 
PPV 9 30.0 6.5-36.5 21 171.0 65.0-376.5 0.002 
PTV 29 11.0 3.0-103.5 11 192.0 26.0-224.0 0.02 
~Mann-Whitney U test; propagation versus rethrombosis time. 
Thrombotic events within segments. The 
timing of thrombotic events occurring after initial 
presentation, as well as their effect on ultimate valve 
function, was addressed within individual venous 
segments. Among extremities with a DVT at presen- 
tation, propagation was observed in 114 of 1037 
(11%) initially tminvolved segments. The incidence 
of propagation (Table II) and the median time to 
propagation (Table III) were not significantly differ- 
ent among any of the eight segments tudied. 
Propagation tended to be the earliest of the three 
events examined, occurring within a median of less 
than 40 days in all segments. 
Rethrombosis during follow-up was noted in 110 
of 799 (13.8%) initially involved segments. Consid- 
ering the DFV and GSV as branches of the axial deep 
venous system, the incidence of rethrombosis was 
significantly higher (p < 0.01) in the axial segments 
than in the nonaxial GSV and DFV segments (Table 
II). The time from presentation to rethrombosis was 
significantly different (p = 0.03) among the eight 
venous egments (Table III). Rethrombosis occurred 
earlier (7.0 to 62.5 days ) in the more cephalad venous 
segments than in the more caudal SFD, PPV, and 
PTV segments (171 to 232.5 days). With the 
exception of the very small number of DFV seg- 
ments, rethrombosis tended to occur later than 
propagation i initially involved extremities. 
Among tminvolved extremities contralateral toa 
DVT, new thrombi were observed in 46 of 1037 
(3.4%) segments. The incidence of new contralat- 
eral thrombi was relatively constant at 2.0% to 4.7% 
across all segments (Table II). Furthermore, in- 
volvement of new segments tended to occur later 
and with a much broader ange in initially unin- 
volved limbs than in extremities with ipsilateral 
propagation (Fig. 3). This difference reached sta- 
tistical significance in SFP, SFD, and PPV segments 
< 0.03). 
Reflux among segments with and without re- 
thrombosis was compared at the last follow-up visit 
after excluding those cases in which the reflux status 
was unknown or indeterminate (Fig. 4). The preva- 
lence of reflux among the cephalad segments (CFV, 
GSV, and DFV) was not substantially different in 
those with and without rethrombosis. However, 
such comparisons are limited by the few numbers of 
GSV and DFV segments with rethrombosis. In the 
more caudal segments, reflux developed more com- 
monly in those segments with rethrombosis. This 
difference in the development of reflux was statisti- 
cally significant in the SFM, SFD, and PPV segments 
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Fig. 4. Reflux in initially involved segments. Reflux status at last follow-up visit among those 
with and without rethrombosis. Numbers above bars indicate number of segments inwhich reflux 
was observed over number of segments inwhich reflux could be definitively assessed. Differences 
between segments with and without rethrombosis are statistically significant (p < 0.005) for 
SFM, SFD, and PPV segments. 
PTV 
(p < 0.005). Consistent with the delayed occurrence 
of rethrombosis, egments with rethrombosis had a 
longer duration of follow-up than segments without 
rethrombosis. When those segments with significant 
differences in the development ofreflux were entered 
into the logistic regression model with duration of 
follow-up, the occurrence of rethrombosis predicted 
the development of reflux independent of follow-up 
interval in the SFM and PPV but not in the SFD 
segments. 
In evaluating segments that thrombosed after 
initial presentation, the development of reflux was 
assumed to be dependent only on the presence or 
absence ofthrombus and not on the status of adjacent 
segments. Segments with propagation and new 
contralateral thrombi were therefore grouped for 
analysis. Segments to which thrombus had extended 
developed reflux in 29% to 50% of cases in compari- 
son to 5.7% to 18,2% of segments that remained 
patent (Fig. 5). This difference was statistically 
significant (p < 0.05) in all eight venous segments. 
There was no significant difference in the duration of 
follow-up among segments that remained patent or 
developed new thrombus during follow-up. 
D ISCUSSION 
Recanalization of venous thrombi s now recog- 
nized as a common phenomenon after an episode of 
acute DVT.  1"4,8,9 Although the nomenclature re- 
mains under debate, the interacting processes of 
thrombus retraction, peripheral fragmentation, and 
fibrinolysis lead to restoration of the venous lumen in 
most cases. 10 However, recurrent thrombotic events 
are also well recognized. Most clinical investigations 
have not distinguished propagation from rethrom- 
bosis and have tended to include pulmonary embo- 
lism with these events. The reported incidence of 
such events varies with treatment, location of the 
thrombus, and duration of follow-up. Recurrent 
thromboembolism has been reported in 0% to 5.2% 
of patients treated with warfarin for 3 months ,  11'12 in 
7% of patients monitored for 9 months after a 
3-month course of warfarin, 13 and in 47% of patients 
treated with low-dose subcutaneous heparin for 3 
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months after a proximal DVT.12 On the basis of the 
literature, Sarasin and Bounameaux 14 calculated a
theoretical recurrence rate of 0.9% per month after 
discontinuing anticoagulant therapy for proximal 
DVT. Investigations using serial imaging studies 
have further elucidated the types and frequencies of 
recurrent thrombotic events. Progression of partially 
occluding thrombus to complete occlusion has been 
described in 29% of limbs monitored with phlebog- 
raphy, is whereas propagation to a more proximal 
level has been reported in 38% of patients monitored 
with serial duplex scanning.16 
The natural history of acute DVT is therefore 
perhaps best regarded as a dynamic balance between 
the competing processes of recanalization and recur- 
rent thrombosis. The occurrence of such conflicting 
processes should not be surprising iven the delicate 
balance between the coagulation and fibrinolytic 
systems. In most patients the overall balance appears 
to favor recanalization early after an acute DVT. 
However, this balance may be tipped in favor of 
further thrombosis by factors uch as ongoing stimuli 
to coagulation, hypercoagulable states, and fibrino- 
lyric deficiencies. Such progressive thrombotic events 
may have important implications for the clinical 
treament and ultimate outcome of such patients. 
As defined in this study, thrombotic events 
occurring after initial presentation may include ex- 
tension of thrombus to an initially uninvolved 
extremity, propagation to new segments in the 
ipsilateral limb, and rethrombosis of partially oc- 
cluded or recanalizcd segments. Whether these vents 
differ in their pathophysiologic mechanism remains 
unknown, although differences in the timing of their 
occurrence suggest that they are indeed distinct 
entities. In this study, propagation to ipsilateral 
segments ended to occur within a median of less than 
40 days. This may suggest persistence of the initial 
thrombotic stimulus. Indeed, the less extensive initial 
involvement in limbs with propagation may reflect 
earlier presentation of these patients. In contrast, 
development ofthrombi in the contralateral limb and 
rethrombosis tended to occur as somewhat later 
events. The more extensive segmental involvement of 
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contralateral extremities further suggests ome dif- 
ference in their pathophysiologic condition. 
In this study further thrombotic events occurred 
in 106 extremities: 97 ipsilateral to the initial 
thrombus and 9 on the contralateral side. This 
represents 48% of initially involved and 6% of 
uninvolved extremities. Among initially involved 
limbs, propagation and rethrombosis occurred with 
similar frequency, with both processes occurring 
together in 13% of extremities. Most importantly, 
these events appear to be detrimental to valve 
function. Disregarding the DFV and GSV segments, 
in which the number of events was quite small, the 
incidence of reflux among segments with rethrom- 
bosis was 36% to 73%. Similarly, initially patent 
segments o which thrombus had extended emon- 
strated a 29% to 50% incidence of reflux. 
Interpretation of the relationship between re- 
thrombosis and reflux is complicated by the longer 
follow-up interval among segments with rethrombo- 
sis. The duration of follow-up does influence the 
incidence of reflux, most likely through the progres- 
sive occurrence of events uch as recanalization a d 
rethrombosis. These longer follow-up intervals 
among segments with rethrombosis most likely 
reflect the observation that rethrombosis tends to 
occur some months after the initial event. Follow-up 
intervals among those segments with and without 
propagation, an earlier event, were not significantly 
different. When the interaction between follow-up 
interval and rethrombosis was examined by use of 
logistic regression, rethrombosis remained an inde- 
pendent predictor of reflux in two of the three 
segments with significant differences inthe univariate 
analysis. 
We have previously demonstrated arly, complete 
recanalization after an episode of acute DVT to be an 
important determinant ofultimate valve function in 
all segments except he posterior tibial vein. 2 De- 
pending on the venous segment, those segments 
eventually developing reflux required 2.3 to 7.3 times 
longer for complete lysis in comparison to those 
segments in which valve function was preserved. 
However, asmall number of patients were also noted 
to have development ofreflux despite arly lysis. It is 
possible that subsequent thrombotic events are re- 
sponsible for the development of reflux in at least 
some of these patients. Such events may also have 
implications for patients treated with thrombolytic 
therapy and indeed rethrombosis rates of 60% after 
treatment with streptokinase have been reported. 17 
Some understanding of the causes of these vents 
and their prevention is essential in minimizing 
development ofthe postthrombotic syndrome. Ana- 
tomically, rethrombosis occurred in limbs with 
significantly more extensive segmental involvement, 
whereas propagation tended to occur in extremities 
with less extensive initial involvement. Systemic 
hypercoagulability or fibrinolytic deficiencies may 
play an important role in uninvolved extremities 
developing DVT. However, the observation that 
thrombosis of initially patent venous segments i  
significantly more common in initially involved 
compared with uninvolved extremities suggests that 
local hemodynamic or morphologic factors play at 
least an important permissive, if not primary, role in 
these cases. None of the three thrombotic events 
examined in this study were significantly associated 
with the clinical risk factors of age, prolonged bed 
rest, recent surgery, malignancy, a family history of 
DVT, trauma, congestive heart failure, recent ex- 
tended travel, use of oral contraceptives, or preg- 
nancy. 
This study only partially addresses the causes of 
further thrombotic events after an episode of acute 
DVT. Unfortunately, because of this study's design 
and referral patterns, the relationship of anticoagu- 
lation to propagation and rethrombosis cannot be 
directly addressed. However, it does seem clear that 
anticoagulation as practiced in the community in- 
completely prevents these vents. At the time of their 
occurrence, 59.0% to 88.9% of patients were receiv- 
ing anticoagulants. This clearly does not imply these 
patients were given therapeutic anticoagulants at the 
time of the event. Inadequate anticoagulation u der 
therapy has been documented in up to 37% of 
patients.16 Although the adequacy of anticoagulation 
was unrelated to thrombus propagation i the study 
ofKrupski et al., 16 a much larger study I1 reported the 
incidence of recurrent venous thromboembolism to 
be 15 times higher among patients with inadequate 
anticoagulation for 24 hours or more after starting 
therapy. 
Furthermore, this study does not address the 
relationship of systemic oagulation and fibrinolytic 
abnormalities torecurrent thrombotic events. Juhan- 
Vague et al.18 reported eficient release of tissue-type 
plasminogen activator in 10% of patients with DVT; 
a finding associated with an increased frequency of 
recurrent thrombotic events. A relationship between 
impaired fibrinolysis and recurrent DVT has been 
suggested by several other investigators, 19,2° al- 
though the methodologic validity of these findings 
has been questioned by others. 2] Deficiencies of the 
coagulation i hibitors antithrombin III, protein C, 
and protein Sare known to be associated with venous 
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thrombosis, although the prevalence of these defi- 
ciencies among patients with DVT is less than 10%. 22 
However, resistance to activated protein C has been 
recently described and appears to be at least 10 times 
more common among patients with DVT than other 
heritable anticoagulant deficiencies. 23 Although the 
relationship of this defect, reported in 33% to 64% 
of patients with DVT,  23'24 to recurrent DVT remains 
to be fully defined, it may have important implica- 
tions for ultimate valve function in these patients. 
Despite these gaps in our knowledge, it is 
becoming clear that venous thrombi undergo a 
dynamic evolution early after the acute event. Re- 
canalization proceeds rapidly in most patients, al- 
though this process is balanced by propagation of 
thrombus to uninvolved segments as an early event. 
Extension of thrombus to contralateral uninvolved 
segments and rethrombosis of involved segments 
tend to occur somewhat later in all but the most 
proximal venous segments. Because such events are 
detrimental to valve competence, identifying patients 
at risk for these events and preventing their occur- 
rence are of importance in preventing the postthrom- 
botic syndrome. For the present, ensuring an ad- 
equate intensity of anticoagulation appears to be 
important on the basis of the work of Hull et al.,n 
whereas identification of biologic markers of a 
thrombotic tendency may have some role in the 
future. 
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